A Magnetic Resonance Imaging Radiomics Signature to Distinguish Benign From Malignant Orbital Lesions
Loïc Duron(Inserm), Augustin Lecler(Université Paris Cité), Julien Savatovsky(Fondation Ophtalmologique Adolphe de Rothschild), Frédérique Charbonneau(Fondation de Rothschild), Alexandre Heraud(Hôpital Paris Saint-Joseph), Laure Fournier(Inserm), Mathieu Zmuda(Fondation Ophtalmologique Adolphe de Rothschild)
Cited by 40
Related Papers
Revolutionizing radiology with GPT-based models: Current applications, future possibilities and limitations of ChatGPT
|Diagnostic and Interventional Imaging|2023|384
METhodological RadiomICs Score (METRICS): a quality scoring tool for radiomics research endorsed by EuSoMII
|Insights into Imaging|2024|286
Detection, Characterization, and Inhibition of FGFR–TACC Fusions in IDH Wild-type Glioma
|Clinical Cancer Research|2015|285
How can we combat multicenter variability in MR radiomics? Validation of a correction procedure
|European Radiology|2020|212